Karla Palmer is speaking at FDLI’s Drug Quality and Security Act Conference
Panelist, Bulk Substances and Essential Copies: Draft Guidance and Recent LitigationWhen
December 4, 2018Where
Hogan Lovells US LLP555 13th St., NW.
Washington, DC 20004
For more information see conference website
Related Professionals
- Karla L. Palmer
Director